Fly News Breaks for July 31, 2019
Jul 31, 2019 | 09:19 EDT
Lake Street analyst Brooks O'Neil affirms a Buy rating on BioTelemetry with a $90 price target after the company reported "another productive quarter." The analyst remains confident the management team will continue to execute. He likes the profitable core cardiac monitoring business at BioTelemetry and sees "significant opportunities" for accelerating organic growth in Geneva, research services, and population health.
News For BEAT From the Last 2 Days
There are no results for your query BEAT